Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials

Abstract Prostate cancer remains a major cause of cancer morbidity and mortality and is rising in incidence across the world. Although a succession of randomised controlled trials have improved outcomes across all stages of disease, there remain significant clinical challenges and unmet needs. Repur...

Descrición completa

Detalles Bibliográficos

Principais autores:	Duncan C. Gilbert, Ruth E. Langley, Dami Ayadi, Mannab Berhanu, Lakshmi Kowdley Hemanth, Seunghee Kwon, Hossameldin Abdallah, Angela Meade, Noel Clarke, Silke Gillessen, Nicholas James, Gauthier Bouche, Mahesh Parmar, Matthew Nankivell, Laura Murphy
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-01-01
Series:	BMC Pharmacology and Toxicology
Acceso en liña:	https://doi.org/10.1186/s40360-025-01077-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!